Emerald Growth Fund Class C HSPCX

Morningstar Medalist Rating
  • NAV / 1-Day Return $11.32  /  +0.80 %
  • Fund Size $1.3B
  • Adjusted Expense Ratio 1.760%
  • Net Expense Ratio 1.680%
  • Fee Level: Distribution Low
  • Share Class Type Level Load
  • Morningstar Category Small Growth
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $2,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 45%

Morningstar’s Analysis HSPCX

Will HSPCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Emerald Growth C holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HSPCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 21.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

F/m Emerald Life Sciences Innovation ETF

6.36 91M
—

Travere Therapeutics Inc Ordinary Shares

2.06 30M
Healthcare

InterDigital Inc

2.05 30M
Technology

AAR Corp

1.85 27M
Industrials

VSE Corp

1.78 26M
Industrials

Sensient Technologies Corp

1.74 25M
Basic Materials

Corcept Therapeutics Inc

1.61 23M
Healthcare

Axos Financial Inc

1.51 22M
Financial Services

Mercury Systems Inc

1.51 22M
Industrials

CECO Environmental Corp

1.44 21M
Industrials

Sponsor Center